Artrya secures UK, EU approvals for Salix
Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the European Union and the United Kingdom for its Salix Coronary Anatomy product.
The AI-powered software identifies and analyses arterial plaque to diagnose coronary artery disease.
The recent certifications allow Artrya to market Salix in 28 EU member countries and...
Brisbane-based digital health company, ResApp Health has announced the launch of SleepCheck, a mobile medical device software application that analyses a user’s breathing and snoring sounds during sleep and provides an assessment of their risk of sleep apnoea.
The app uses the smartphone’s built-in microphone to record the user’s breathing and snoring sounds while they sleep. SleepCheck’s...
Toumaz, a wireless medical sensor company based in the United Kingdom, told investors that it has made operational strides for both healthcare industry products and consumer-focused initiatives. While Toumaz launched its CE marked Life Pebble late last year, it has plans to submit an end-to-end wireless vital signs monitoring system for FDA clearance and a CE mark later next year.
Toumaz said its...
